a b s t r a C t acute lung injury (ali) and its more severe form, acute respiratory distress syndrome (ards), are important critical care syndromes for which the treatment options are limited once the condition is fully established. enormous basic and clinical research efforts have led to improvements in supportive treatment, but surprisingly little has been done on the prevention of this devastating syndrome. the development and progression of ali/ards may be triggered by various intrahospital exposures including but not limited to transfusion, aspiration, mechanical ventilation, certain medications and delayed treatment of shock and infection. early recognition of patients with or at risk of ali/ards is essential for designing novel prevention and treatment strategies. automated electronic screening tools and novel scoring systems applied at the time of hospital admission may facilitate enrolment of patients into mechanistic and outcome studies, as well as future ali/ards prevention trials.
Insufficient understanding of the clinical development and progression of ALI precludes the design of preventive strategies at the present time. While some studies have suggested potentially important roles of several environmental risk modifiers, 4-12 the knowledge gap persists, with limited understanding of why some patients with septic shock, trauma or pneumonia do and others do not develop ALI. Preclinical studies support a 'two hit' model of development of ALI/ARDS whereby different exposures modify the expression of ALI/ARDS in the primed or susceptible host. 13 For example, common critical care exposures such as mechanical ventilation 14 and transfusion 15 greatly influence the development of ALI in preclinical models, and the 'two hit' experiments are considered to more accurately represent the clinical setting. 13 Preliminary clinical data suggest that ALI/ARDS is rarely present at the time of hospital admission, but develops over a period of hours to days in subsets of patients with predisposing conditions, such as pneumonia, sepsis, trauma and shock and corresponding medical and surgical interventions.
16,17 e a r l y i d e n t i f i C a t i o n o f p a t i e n t s w i t h a l i / a r d s electronic surveillance for ali/ards
Critical care syndromes such as ALI/ARDS are not routinely coded in hospital databases and are greatly under recognised by bedside providers. Although a standardised definition has existed for more than a decade, 18 efforts required for data collection and screening have significantly limited clinical studies in this area. In a recent study, only 27% of ALI episodes were documented by bedside providers.
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The advancement of electronic medical records (EMR) provides the opportunity for electronic screening (syndrome surveillance) of ALI/ARDS and related syndromes. Our team has developed and validated a novel syndrome surveillance tool (ALI 'sniffer') for the recognition of patients with ALI and ARDS ( figure 1).
19 Electronic alert is triggered by the following combination of observations: the ratio of partial pressure of oxygen to inspired oxygen concentration (PaO 2 / FIO 2 ) <300 and chest radiograph report (free text Boolean query containing trigger words: ('bilateral' AND 'infiltrate') OR 'edema'. With an excellent negative predictive value (0.99, 95% CI 0.98 to 1.00), ALI sniffer is optimised for screening patients with a high probability of ALI/ARDS. It has been continuously running since December 2005, allowing prospective identification of ALI/ARDS cases. Azzam et al. 20 have recently reported similar results. Using the American European Consensus Conference (AECC) criteria, 18 excluding current or known history of congestive heart failure, the automated screening tool had a sensitivity of 87%, specificity of 89% and accuracy of 88% in capturing patients with ALI/ARDS. Although currently limited to a minority of institutions, electronic screening has a very promising potential application in both clinical settings and research.
high-resolution monitoring of ali/ards development A standardised ALI assessment method based on the AECC definition 21 facilitated diagnosis of ALI/ARDS for clinical research and quality improvement projects in our institution. 22 The absence of left atrial hypertension as a primary explanation for pulmonary oedema is excluded by integrated clinical evaluation based on the combination of echocardiographic findings (E/E' <15), brain natriuretic peptide levels (BNP <250 pg/ml in the absence of renal failure), venous filling pressures (PAOP ≤18 cm H 2 O or CVP <15 cm H 2 O in the absence of pulmonary hypertension) and the response to therapy (brisk response to diuretics and positive pressure ventilation favours hydrostatic oedema). This process yielded good inter-observer agreement for differentiation between ALI and hydrostatic oedema (kappa values from 0.65 to 0.83). 22, 23 Since most clinical studies to date have been limited by a low temporal resolution ('today the patient does not have ALI and tomorrow he/she does'), it has been very difficult to distinguish between the cause and effect role of specific risk factors (effect-cause bias). High-resolution monitoring of hospitalised patients allows us to pinpoint the beginning of respiratory worsening based on the sustained changes in respiratory rate and the ratio of arterial oxygen saturation over inspired oxygen concentration (SpO 2 /FIO 2 ) without being dependent on bedside providers ordering arterial blood gas (ABG) analysis. Rice et al. 24 recently validated SpO 2 /FIO 2 thresholds against the gold standard of ABG. SpO 2 /FIO 2 <315 corresponds to ALI (PaO 2 /FIO 2 <300) and SpO 2 /FIO 2 <235 corresponds to ARDS (PaO 2 /FIO 2 <200). Hence, early identification of ALI/ARDS could be done without arterial blood gas confirmation which could cause delay in diagnosis and treatment as well as enrolment in clinical trials. In figure 2 the black arrow points to a sustained decrease in oxygen saturation followed by an increase in oxygen supplementation at 1 AM suggesting the onset of respiratory worsening. The chest radiograph and blood gas analysis performed five hours later (6 AM) confirmed ALI, but only exposures occurring before 1 AM were considered in the analysis. This conservative approach minimises the effect-cause bias in this type of association study. Our group has used this approach to identify exposures of interest related to transfusions, 6 antibiotic management 25 and goal-directed resuscitation.
i d e n t i f i C a t i o n o f p a t i e n t s a t r i s K o f d e v e l o p i n g a l i a n d a r d s
One of the principal barriers towards better understanding of clinical pathogenesis of ALI/ARDS and the design of effective ALI/ARDS preventive strategies is the fact that previous clinical studies focused exclusively on patients admitted to the ICU. While multiple studies around the world reported figure 1. Electronic surveillance for acute lung injury (ALI 'sniffer') the risk factors for ALI/ARDS, 26-29 only a few prospectively followed patients with predisposing conditions to document the probability of developing ALI/ARDS. Landmark studies by Pepe et al., 30 Fowler et al. 31 and Hudson et al. 32 were conducted in the early 1980s and 1990s, before the current definitions of ALI and ARDS, sepsis and pneumonia were established. Recent cohort studies used specific definitions but were still restricted to patients admitted to the ICU. 5, 12, [33] [34] [35] 10, 11, 36 The proportion of patients with risk factors who develop ALI/ARDS drops drastically when assessed at the time of hospital admission. 17 In a recent study by Ferguson et al. 17 only 7% of hospitalised patients with sepsis, 2% with pancreatitis, 10% with pneumonia and 15% with witnessed aspiration developed ALI. 17 Many patients with predisposing conditions never develop ALI/ARDS and are never admitted to the ICU 17 making the enrolment of non-selected patients into ALI/ARDS prevention studies neither practical nor efficient without a method to select high-risk patients. To facilitate enrolment of patients into mechanistic and outcome studies as well as future ALI/ARDS prevention trials, our group has recently developed an ALI/ARDS prediction model, 37 (the Lung Injury Prediction Score: LIPS) which incorporates demographic, environmental and clinical characteristics at the time of, and before hospital admission. LIPS takes into consideration not only different incidences of ALI/ARDS depending on underlying risk factors (from 2% risk in patients with uncomplicated pancreatitis 17 up to 40% in those with septic shock 38 ) but also the presence of significant risk modifiers (smoking, 39 alcohol, 10,40 diabetes mellitus, 11 chemotherapy, 38 hypoalbuminaemia, 41 and respiratory rate 5 ). If prospectively validated and refined in relevant patient populations, this model could serve to define the patients at high risk of ALI/ ARDS in whom future mechanistic studies and ALI/ARDS prevention trials will be conducted. By determining not only patients at high risk but also the attributable burden of ALI/ARDS in contemporary cohorts of patients at risk, the findings are expected to facilitate the prioritisation of preventive strategies and future clinical trials. Another recent study 42 reported that patients who require high oxygen supplementation when in the emergency room (O 2 >2 l/min) are more likely to progress into ALI. In addition, the authors defined a clinical diagnosis of early ALI in patients who present at hospital admission with bilateral opacities on chest radiograph not exclusively due to left atrial hypertension and who initially required oxygen supplementation of >2 l/min (73% sensitive and 79% specific for progression to ALI with respiratory failure).
C o n C l u s i o n
ALI/ARDS is rarely present at the time of hospital admission. Subsequent ('second hit') hospital exposures have modified the development and expression of the syndrome in patients with predisposing conditions. Therefore, ALI/ARDS may be viewed as a potentially preventable healthcare-acquired complication analogous to venous thromboembolism, stress ulcer bleeding or nosocomial infections. Preliminary studies suggest that early treatment of shock and infection 38 and avoidance of ventilator and transfusion-related lung injury 43 may reduce the incidence of hospital-acquired ALI/ARDS.
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Electronic surveillance and novel scoring systems for early identification of patients with or at risk of ALI/ARDS will facilitate future mechanistic studies and ALI/ARDS prevention trials. the black arrow points to a sustained decrease in oxygen saturation followed by an increase in oxygen supplementation at 01.00 aM suggesting the onset of respiratory worsening. the chest radiograph and blood gas analysis performed five hours later (06.00) confirmed ali. r e f e r e n C e s
